JoEllen Weaver

ORCID: 0000-0002-0596-0188
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • BRCA gene mutations in cancer
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Head and Neck Cancer Studies
  • Genetic Associations and Epidemiology
  • Cancer Genomics and Diagnostics
  • Genetics, Bioinformatics, and Biomedical Research
  • Colorectal and Anal Carcinomas
  • Gene expression and cancer classification
  • Molecular Biology Techniques and Applications
  • Nutrition, Genetics, and Disease
  • CRISPR and Genetic Engineering
  • Computational Drug Discovery Methods
  • COVID-19 and healthcare impacts
  • COVID-19 Impact on Reproduction
  • Genomics and Rare Diseases
  • RNA modifications and cancer
  • Bioinformatics and Genomic Networks
  • COVID-19 epidemiological studies
  • RNA and protein synthesis mechanisms
  • Chromatin Remodeling and Cancer
  • Pregnancy and Medication Impact
  • Peptidase Inhibition and Analysis
  • SARS-CoV-2 detection and testing
  • Long-Term Effects of COVID-19

University of Pennsylvania
2015-2025

University of Pennsylvania Health System
2023-2025

Penn Center for AIDS Research
2024

California University of Pennsylvania
2020-2024

Fox Chase Cancer Center
2009-2023

Regeneron (United States)
2023

Palmetto Hematology Oncology
2023

Translational Therapeutics (United States)
2019-2022

Children's Hospital of Philadelphia
2020

Hutchison/MRC Research Centre
2015

Nasim Mavaddat Daniel Barrowdale Irene L. Andrulis Susan M. Domchek Diana Eccles and 95 more Heli Nevanlinna Susan J. Ramus Amanda B. Spurdle Mark E. Robson Mark E. Sherman Anna Marie Mulligan Fergus J. Couch Christoph Engel Lesley McGuffog Sue Healey Olga M. Sinilnikova Melissa C. Southey Mary Beth Terry David E. Goldgar Frances P. O’Malley Esther M. John Ramūnas Janavičius Laima Tihomirova Thomas van Overeem Hansen Finn C. Nielsen Ana Osório Alexandra Stavropoulou Javier Benı́tez Siranoush Manoukian Bernard Peissel Monica Barile Sara Volorio Barbara Pasini Riccardo Dolcetti Anna Laura Putignano Laura Ottini Paolo Radice Ute Hamann Muhammad Usman Rashid Frans B.L. Hogervorst Mieke Kriege Rob B. van der Luijt Susan Peock Debra Frost D. Gareth Evans Carole Brewer Lisa Walker Mark T. Rogers Lucy Side Catherine Houghton JoEllen Weaver Andrew K. Godwin Rita K. Schmutzler Barbara Wappenschmidt Alfons Meindl Karin Kast Norbert Arnold Dieter Niederacher Christian Sutter Helmut Deißler Doroteha Gadzicki Sabine Preisler‐Adams Raymonda Varon-Mateeva Ines Schönbuchner Heidrun Gevensleben Dominique Stoppa‐Lyonnet Muriel Belotti Laure Barjhoux Claudine Isaacs Beth N. Peshkin Trinidad Caldés Miguel de la Hoya Carmen Cañadas Tuomas Heikkinen Päivi Heikkilä Kristiina Aittomäki Ignacio Blanco Conxi Lázaro Joan Brunet Bjarni A. Agnarsson Aðalgeir Arason Rósa B. Barkardóttir Martine Dumont Jacques Simard Marco Montagna Simona Agata Emma D’Andrea Max Yan Stephen B. Fox Timothy R. Rebbeck Wendy S. Rubinstein Nadine Tung Judy E. Garber Xianshu Wang Zachary Fredericksen V. Shane Pankratz Noralane M. Lindor Csilla I. Szabo Kenneth Offit Rita A. Sakr

Abstract Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their pathology. Analysis of larger datasets mutation carriers should allow further tumor characterization. Methods: We used data from 4,325 2,568 to analyze the pathology invasive breast, ovarian, contralateral cancers. Results: There was strong evidence proportion estrogen receptor (ER)-negative decreased with age at diagnosis among (P-trend = 1.2 × 10−5), but increased BRCA2, 6.8 10−6)....

10.1158/1055-9965.epi-11-0775 article EN Cancer Epidemiology Biomarkers & Prevention 2012-01-01

Limited data are available for pregnant women affected by SARS-CoV-2. Serological tests critically important determining SARS-CoV-2 exposures within both individuals and populations. We validated a spike receptor binding domain serological test using 834 pre-pandemic samples 31 from COVID-19 recovered donors. then completed testing of 1,293 parturient at two centers in Philadelphia April 4 to June 3, 2020. found 80/1,293 (6.2%) possessed IgG and/or IgM SARS-CoV-2-specific antibodies....

10.1126/sciimmunol.abd5709 article EN cc-by Science Immunology 2020-07-03

The Penn Medicine BioBank (PMBB) is an electronic health record (EHR)-linked biobank at the University of Pennsylvania (Penn Medicine). A large variety health-related information, ranging from diagnosis codes to laboratory measurements, imaging data and lifestyle integrated with genomic biomarker in PMBB facilitate discoveries translational science. To date, 174,712 participants have been enrolled into PMBB, including approximately 30% non-European ancestry, making it one most diverse...

10.3390/jpm12121974 article EN Journal of Personalized Medicine 2022-11-29

Susceptibility to testicular germ cell tumors (TGCT) has a significant heritable component, and genome-wide association studies (GWASs) have identified with variants in several genes, including KITLG , SPRY4 BAK1 TERT DMRT1 ATF7IP . In our GWAS, we genotyped 349 TGCT cases 919 controls replicated top hits an independent set of 439 960 attempt find novel susceptibility loci. We second marker (rs7040024) the doublesex mab-3-related transcription factor 1 ( ) gene that is previously described...

10.1093/hmg/ddr207 article EN Human Molecular Genetics 2011-05-06

Hereditary transthyretin (TTR) amyloid cardiomyopathy (hATTR-CM) due to the TTR V122I variant is an autosomal-dominant disorder that causes heart failure in elderly individuals of African ancestry. The clinical associations carrying variant, its effect other ancestry populations including Hispanic/Latino individuals, and rates achieving a diagnosis carriers are unknown.To assess association between identify hATTR-CM among with failure.Cross-sectional analysis noncarriers aged 50 years or...

10.1001/jama.2019.17935 article EN JAMA 2019-12-10

Abstract Triple-negative breast cancers are an aggressive subtype of cancer with poor survival, but there remains little known about the etiologic factors that promote its initiation and development. Commonly inherited risk identified through genome-wide association studies display heterogeneity effect among subtypes as defined by status estrogen progesterone receptors. In Triple Negative Breast Cancer Consortium (TNBCC), 22 common susceptibility variants were investigated in 2,980 Caucasian...

10.1158/0008-5472.can-11-1266 article EN Cancer Research 2011-08-16

Importance Polygenic risk scores (PRSs) for coronary heart disease (CHD) are a growing clinical and commercial reality. Whether existing provide similar individual-level assessments of susceptibility remains incompletely characterized. Objective To characterize the agreement CHD PRSs that perform similarly at population level. Design, Setting, Participants Cross-sectional study participants from diverse backgrounds enrolled in All Us Research Program (AOU), Penn Medicine BioBank (PMBB),...

10.1001/jama.2024.23784 article EN JAMA 2024-11-16
Kristen N. Stevens Zachary Fredericksen Celine M. Vachon Xianshu Wang Sara Margolin and 95 more Annika Lindblom Heli Nevanlinna Dario Greco Kristiina Aittomäki Carl Blomqvist Jenny Chang‐Claude Alina Vrieling Dieter Flesch‐Janys Hans‐Peter Sinn Shan Wang‐Gohrke Stefan Nickels Hiltrud Brauch Yon‐Dschun Ko Hans‐Peter Fischer Rita K. Schmutzler Thomas Ind Claus R. Bartram Sarah Schott Christoph Engel Andrew K. Godwin JoEllen Weaver Harsh B. Pathak Priyanka Sharma Hermann Brenner Heiko Müller Volker Arndt Christa Stegmaier Penelope Miron Drakoulis Yannoukakos Alexandra Stavropoulou George Fountzilas Helen Gogas Ruth Swann Miriam Dwek Annie Perkins Roger L. Milne Javier Benı́tez María Pilar Zamora José Ignacio Arias Pérez Stig E. Bojesen Sune F. Nielsen Børge G. Nordestgaard Henrik Flyger Pascal Guénel Thérèse Truong F. Ménégaux Emilie Cordina‐Duverger Barbara Burwinkel Frederick Marmé Andreas Schneeweiß Christof Sohn Elinor J. Sawyer Ian Tomlinson Michael J. Kerin Julian Peto Nichola Johnson Olivia Fletcher Isabel dos‐Santos‐Silva Peter A. Fasching Matthias W. Beckmann Arndt Hartmann Arif B. Ekici Artitaya Lophatananon Kenneth Muir Puttisak Puttawibul Surapon Wiangnon Marjanka K. Schmidt Annegien Broeks Linde M. Braaf Efraim H. Rosenberg John L. Hopper Carmel Apicella Daniel J. Park Melissa C. Southey Anthony J. Swerdlow Alan Ashworth Nick Orr Minouk J. Schoemaker Hoda Anton‐Culver Argyrios Ziogas Leslie Bernstein Christina Clarke Dur Chen‐Yang Shen Jyh-Cherng Yu Huan-Ming Hsu Chia‐Ni Hsiung Ute Hamann Thomas Dünnebier Thomas Rüdiger Hans Ulrich Ulmer Paul D.P. Pharoah Alison M. Dunning Manjeet K. Humphreys Qin Wang Angela Cox

Abstract The 19p13.1 breast cancer susceptibility locus is a modifier of risk in BRCA1 mutation carriers and also associated with the ovarian cancer. Here, we investigated variation subtypes, defined by estrogen receptor (ER), progesterone (PR), human epidermal growth factor receptor-2 (HER2) status, using 48,869 cases 49,787 controls from Breast Cancer Association Consortium (BCAC). Variants were not overall or ER-positive but significantly ER-negative [rs8170 OR, 1.10; 95% confidence...

10.1158/0008-5472.can-11-3364 article EN Cancer Research 2012-02-14

SUMMARY Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread within the human population. Although SARS-CoV-2 is a novel coronavirus, most humans had been previously exposed to other antigenically distinct common seasonal coronaviruses (hCoVs) before COVID-19 pandemic. Here, we quantified levels of SARS-CoV-2-reactive antibodies and hCoV-reactive in serum samples collected from 204 We then pre-pandemic antibody separate cohort 252 individuals who became...

10.1101/2020.11.06.20227215 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-11-10

It is important to determine if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and SARS-CoV-2 mRNA vaccinations elicit different types of antibodies. Here, we characterize the magnitude specificity spike-reactive antibodies from 10 acutely infected health care workers with no prior exposure history 23 participants who received vaccines. We found that infection primary vaccination S1- S2-reactive antibodies, while secondary boosts mostly S1 Using absorption assays, a...

10.1016/j.celrep.2022.111496 article EN cc-by-nc-nd Cell Reports 2022-10-01

Prospective clinical research studies are essential for determining the effectiveness and safety of drugs, medical devices, healthcare delivery interventions. However, low enrollment, particularly among Black Hispanic patients, challenges generalizability results fairness research. Leveraging insights from behavioral economics to modify content messages recruiting patients join may increase enrollment representativeness trial populations. Method outreach, source message framing, financial...

10.1016/j.ahj.2025.03.016 article EN cc-by American Heart Journal 2025-03-01

Some studies suggest that recent common coronavirus (CCV) infections are associated with reduced COVID-19 severity upon SARS-CoV-2 infection. We completed serological assays using samples collected from health care workers to identify antibody types protection and symptom duration. Rare cross-reactive antibodies elicited by past CCV were not protection; however, the duration of symptoms following was significantly in individuals higher betacoronavirus (βCoV) titers. Since titers decline over...

10.1172/jci.insight.150449 article EN cc-by JCI Insight 2021-07-08

Identification of germline mutations in DNA repair genes has significant implications for the personalized treatment individuals with prostate cancer (PrCa). To determine associated localized PrCa a diverse academic biobank and to genetic testing burden. A cross-sectional study 2391 patients was carried out. Genetic ancestry mutation rates (excluding somatic interference) 17 were determined 1588 3273 cancer-free males. Burden within genetically European (EUR) African (AFR) performed between...

10.1016/j.eururo.2021.09.029 article EN cc-by-nc-nd European Urology 2021-10-25
Dylane Wineland Anh N. Le Ryan Hausler Gregory J. Kelly Emanuel Barrett and 95 more Heena Desai Bradley Wubbenhorst John Pluta Paul Bastian Heather Symecko Kurt D’Andrea Abigail Doucette Peter Gabriel Kim A. Reiss Anupma Nayak Michael D. Feldman Susan M. Domchek Katherine L. Nathanson Kara N. Maxwell Adam J. Mansfield Adam E. Locke Afiya Poindexter Alan R. Shuldiner Alexander Li Alexander Lopez Alicia Hawes Amelia Averitt Amy Damask Andrew Deubler Andrey Ziyatdinov Anthony Marcketta Anurag Verma Arden Moscati Ariane Ayer Aris Baras Aris N. Economides Arkopravo Ghosh Ashlei Brock Ashley Kloter Ayesha Rasool Ayşegül Güvenek Bin Ye Blair Zhang Boris Boutkov Caitlin Forsythe Carlo Sidore Charles Paulding Christina Beechert Christopher E. Gillies Colleen Morse Dadong Li Daniel J. Rader Daren Liu Deepika Sharma Eli A. Stahl Eric Jorgenson Erin D. Fuller Esteban Chen Evan K. Maxwell Fred Vadivieso Gannie Tzoneva George Hindy George Mitra Giovanni Coppola Gisu Eom Gonçalo R. Abecasis Hyun Min Kang Jack A. Kosmicki Jaimee Hernandez Jan Freudenberg Jason Mighty Jeffrey Staples Jeffrey G. Reid Joelle Mbatchou JoEllen Weaver John D. Overton Jonas Bovijn Jonathan Marchini Joseph Dunn Joshua Backman Juan Rodriguez-Flores Katherine Siminovitch Kathie Sun Kavita Praveen K D Husain Kia Manoochehri Kyoko Watanabe Lauren Gurski Lee Dobbyn Linda Morrel Louis Widom Luca A. Lotta Lukas Habegger Lyndon J. Mitnaul Manasi Pradhan Manav Kapoor Manuel Allen Revez Ferreira Marcus B. Jones Maria Sotiropoulos Padilla Marjorie Risman

PURPOSE Breast and ovarian tumors in germline BRCA1/2 carriers undergo allele-specific loss of heterozygosity, resulting homologous recombination deficiency (HRD) sensitivity to poly-ADP-ribose polymerase (PARP) inhibitors. This study investigated whether biallelic HRD also occur primary nonbreast/ovarian that arise carriers. METHODS A clinically ascertained cohort with a cancer was identified, including canonical (prostate pancreatic cancers) noncanonical (all other) tumor types....

10.1200/po.23.00036 article EN cc-by-nc-nd JCO Precision Oncology 2023-08-01

Abstract Purpose: Multimodality treatment of squamous cell carcinoma the head and neck (SCCHN) often involves radiotherapy cisplatin-based therapy. Elevated activity DNA repair mechanisms, such as nucleotide excision (NER) pathway, which ERCC1 is a rate-limiting element, are associated with cisplatin possibly RT resistance. We have determined cross-complementing group 1 (ERCC1) expression in human papillomavirus (HPV)-negative SCCHN treated surgery [±adjuvant radiotherapy/chemoradiation...

10.1158/1078-0432.ccr-13-0152 article EN Clinical Cancer Research 2013-10-03

SARS-CoV-2 infection of vaccinated individuals is increasingly common but rarely results in severe disease, likely due to the enhanced potency and accelerated kinetics memory immune responses. However, there have been few opportunities rigorously study early recall responses during human viral infection. To better understand identify potential mediators lasting vaccine efficacy, we used high-dimensional flow cytometry antigen probes examine longitudinal samples from infected Omicron wave....

10.1101/2023.02.05.527215 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-02-06

A paucity of information exists on the recruitment Asian Americans for biospecimen research. Although studies show that Chinese are at high risk hepatitis B virus (HBV) infection, little is known about their willingness to participate in HBV-related research and how knowledge, attitudes, cultural factors impact participate. The study was guided by Community-Based Participatory Research principles. Data were derived from an assessment participation among Philadelphia region. conducted with...

10.1089/bio.2013.0081 article EN Biopreservation and Biobanking 2014-04-01

Abstract Limited data are available for pregnant women affected by SARS-CoV-2. Serological tests critically important to determine exposure and immunity SARS-CoV-2 within both individuals populations. We completed serological testing of 1,293 parturient at two centers in Philadelphia from April 4 June 3, 2020. tested 834 pre-pandemic samples collected 2019 15 COVID-19 recovered donors validate our assay, which has a ∼1% false positive rate. found 80/1,293 (6.2%) possessed IgG and/or IgM...

10.1101/2020.07.08.20149179 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-07-10

The study of muscle mass as an imaging-derived phenotype (IDP) may yield new insights into determining the normal and pathologic variations in population. This can be done by 3D abdominal from 12 distinct regions groups using computed tomography (CT) a racially diverse medical biobank. To develop fully automatic technique for assessment CT IDPs preliminarily determine IDP with age sex clinically retrospective was conducted Penn Medicine BioBank (PMBB), research protocol that recruits adult...

10.1038/s41598-024-64603-6 article EN cc-by Scientific Reports 2024-06-26
Coming Soon ...